ArticleScientific reports2026
Imperatorin restores behavioral and recognition memory deficits induced by REM sleep deprivation in male rats.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many studies have shown the deleterious effects of rapid-eye movement (REM) sleep deprivation (SD) on cognitive functions and synaptic plasticity markers. On the other hand, imperatorin (IMP, extracted from the fruits of Angelica dahurica and Peucedanum praeruptorum) may exert significant pro-cognitive and neuroprotective effects. The present study aimed to explore the potential therapeutic effects of IMP on behavioral and molecular changes induced by REM SD, before or after training in the novel object recognition (NOR) memory test. REM SD was done for 24 h and IMP was orally administered at the dose of 100 mg/kg (immediately after REM SD). Locomotion, anxiety-like behavior, and brain-derived neurotrophic factor (BDNF) and cAMP response element binding (CREB) levels were also assessed in the prefrontal cortex. The results showed that REM SD impaired NOR memory, reduced locomotor activity, increased anxiety- and depressive-like behaviors, with more severe effects of the post-train REM SD. Both pre- and post-train REM SD reduced BDNF and CREB mRNA expression levels in the prefrontal cortex. IMP could restore and increase BDNF and CREB expression levels, respectively, only in pre-train REM SD rats, and reduce behavioral impairments caused by pre- or post-train REM SD. In conclusion, imperatorin attenuated REM SD-induced recognition-memory and behavioral abnormalities, whereas its molecular effects were more selective and were limited to BDNF and CREB mRNA expression changes in the prefrontal cortex, particularly in the pre-train REM SD condition. These findings suggest that BDNF/CREB-related transcriptional modulation may contribute to, but may not fully explain, the behavioral effects of imperatorin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.